Up to 40% of patients with classic hairy cell leukemia relapse within 10 to 15 years. An NIH researcher explains how adding Rituxan up front may help.
|Articles|February 20, 2019
Important Resources
A list of helpful resources to assist people with CLL and their families cope with the emotional and practical aspects of the disease.
Advertisement
Managing the financial aspects of care can be overwhelming for patients and caregivers as they apply for health insurance, file insurance claims and make co-payments. The Leukemia & Lymphoma Society provides resources to help people who are facing these challenges.
- Copay assistance: Financial support eases the cost of copayments or insurance premiums for prescription drugs.
- Susan Lang Pay-It Forward Patient Travel Assistance: Blood cancer patients who have significant financial need may qualify to receive financial assistance for ground transportation, air travel and lodging expenses related to their care.
- Other resources: Additional information may lead to more assistance with prescription drug and stem cell transplantation costs.
- Most drug companies have programs for qualifying patients to mitigate the cost of cancer drugs.
The
Advertisement
Related to this article
A new trial will test whether a set course of Brukinsa plus sonrotoclax, which target two pathways that drive hairy cell leukemia, can offer an alternative to chemotherapy.
An experimental treatment has kept one patient with heavily pretreated hairy cell leukemia free of detectable disease for more than two years, raising questions about whether CAR T-cell therapy could offer a path toward a cure.
Advertisement
Advertisement
Trending on CURE
1
What Is a Whipple Procedure? Pancreatic Cancer Surgery Explained
2
Datroway Slows Brain Metastases in Triple-Negative Breast Cancer
3
Weight Loss With Pancreatic Cancer: Why It Happens and What Helps
4
Glioblastoma Patients Can Request Genomic Testing on Their Tumor Tissue
5